CORDIS · 696579 · H2020
FrEBT Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device
Coordinator: COMAC MEDICAL LTD (BG)
The innovation project objectives are to: 1/prove through a feasibility study the potential to validate the Fractional Exhaled Breath Temperature, via new viable and disruptive technological device, as a diagnostic, prognostic and monitoring biomarker for inflammatory and obstructive pulmonary diseases; 2/enhance the competitiveness and profitability of the full- service clinical research organization COMAC MEDICAL Ltd., operating via own network of partners in 14 countries from 3 European regions with population of over 118 mln.The commercial potential of the innovative solution is that it i…
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
Co-funding: the European Union contributes €50k toward a total project budget of €71k — a funding rate of 70%, with the remainder covered by the consortium partners. The project runs over approximately 0.2 years from 2015-09-01 to 2015-10-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from BG
see all →- H2START — Green Innovations in Hydrogen for Sustainable Energy Transition101136692 · HORIZON · €15.0M
- PlantaSYST — Establishment of a Center of Plant Systems Biology and Biotechnology for the translation of fundamental research into sustainable bio-based technologies in Bulgaria739582 · H2020 · €14.9M
- BRAIN PP — Bulgarian Robotics & AI Nexus - Where Human Ingenuity meets Artificial Intelligence101250707 · HORIZON · €10.0M
- ODYSSEUS — PREVENTING, COUNTERING, AND INVESTIGATING TERRORIST ATTACKS THROUGH PROGNOSTIC, DETECTION, AND FORENSIC MECHANISMS FOR EXPLOSIVE PRECURSORS101021857 · H2020 · €5.0M
- VELES — VELES Excellence Hub - Strengthening the South-East Europe Smart Health Regional Excellence and Boosting the Innovation Potential101087483 · HORIZON · €4.8M
- INERA — Research and Innovation Capacity Strengthening of ISSP-BAS in Multifunctional Nanostructures316309 · FP7 · €4.1M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the SME-1 funding scheme.
- What is the EU contribution?
- The European Commission contributes €50k toward a total project budget of €71k.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-SMEInst-2014-2015.
- Who coordinates the project?
- The project is coordinated by COMAC MEDICAL LTD (BG).
- What is the project timeline?
- The project runs from 2015-09-01 to 2015-10-31 — approximately 0.2 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 696579.